ASCLETIS-B: GRANT OF SHARE OPTIONS
Jan 3 17:30
ASCLETIS-B: GRANT OF SHARE OPTIONS
Dec 30, 2022 17:36
ASCLETIS-B: GRANT OF SHARE OPTIONS
Jun 30, 2022 17:40
ASCLETIS-B: GRANT OF SHARE OPTIONS
Mar 31, 2022 17:53
ASCLETIS-B: ANNOUNCEMENT - INSIDE INFORMATION - ASCLETIS EXPANDS RITONAVIR ORAL TABLET PRODUCTION AND ANNOUNCES ORAL DIRECT-ACTING ANTIVIRAL PIPELINE AGAINST SARS-COV-2 VIRUS
Jan 3, 2022 08:00
ASCLETIS-B: EXCHANGE NOTICE - RESUMPTION OF TRADING
Dec 3, 2021 12:40
ASCLETIS-B: ANNOUNCEMENT - INSIDE INFORMATION - INCLUSION IN NEW CATALOGUE OF CHINA NATIONAL REIMBURSEMENT DRUG LIST (NRDL) OF ASCLEVIR/GANOVO REGIMEN, AN ALL-ORAL DIRECT ANTI-HCV THERAPY AND RESUMPTION OF TRADING
Dec 3, 2021 12:00
ASCLETIS-B: TRADING HALT
Dec 3, 2021 10:54
ASCLETIS-B: EXCHANGE NOTICE - TRADING HALT
Dec 3, 2021 09:43
ASCLETIS-B: GRANT OF SHARE OPTIONS
Sep 30, 2021 19:59
ASCLETIS-B: GRANT OF SHARE OPTIONS
Jun 30, 2021 18:30
ASCLETIS-B: GRANT OF SHARE OPTIONS
Apr 7, 2021 19:23
ASCLETIS-B: GRANT OF SHARE OPTIONS
Mar 31, 2021 18:25
ASCLETIS-B: GRANT OF SHARE OPTIONS
Dec 31, 2020 16:18
ASCLETIS-B: GRANT OF SHARE OPTIONS
Mar 31, 2020 20:51
ASCLETIS-B: VOLUNTARY ANNOUNCEMENT - INCREASE IN SHAREHOLDING BY DIRECTORS AND CONTROLLING SHAREHOLDERS
Oct 17, 2019 18:00
ASCLETIS-B: Proposal for Adoption of Share Option Scheme and Notice of Extraordinary General Meeting
May 16, 2019 19:39
No Data
No Data